ATE478687T1 - Zur mutation geeignete einzelsträngige oligonukleotid vektoren - Google Patents

Zur mutation geeignete einzelsträngige oligonukleotid vektoren

Info

Publication number: ATE478687T1
Authority: AT; Austria
Prior art keywords: effective; oligodeoxynucleotides; mutation; single stranded; stranded oligonucleotide
Prior art date: 1999-08-27

Application number

AT00959442T

Other languages

English (en)

Inventor

Richard Metz

Bruce Frank

Debra Walther

Original Assignee

Valigen Us Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-08-27

Filing date

2000-08-25

Publication date

2010-09-15

2000-08-25 Application filed by Valigen Us Inc filed Critical Valigen Us Inc

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE478687T1 publication Critical patent/ATE478687T1/de

Links

108091034117 Oligonucleotide Proteins 0.000 title abstract 2
230000035772 mutation Effects 0.000 title 1
239000013598 vector Substances 0.000 title 1
229940046166 oligodeoxynucleotide Drugs 0.000 abstract 4
210000004027 cell Anatomy 0.000 abstract 2
241000894006 Bacteria Species 0.000 abstract 1
108091028664 Ribonucleotide Proteins 0.000 abstract 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
230000002068 genetic effect Effects 0.000 abstract 1
210000003494 hepatocyte Anatomy 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
210000004962 mammalian cell Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000004048 modification Effects 0.000 abstract 1
238000012986 modification Methods 0.000 abstract 1
125000003729 nucleotide group Chemical group 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000002336 ribonucleotide Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Crystallography & Structural Chemistry (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicinal Preparation (AREA)
Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

AT00959442T 1999-08-27 2000-08-25 Zur mutation geeignete einzelsträngige oligonukleotid vektoren ATE478687T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/384,960 US6271360B1 (en)	1999-08-27	1999-08-27	Single-stranded oligodeoxynucleotide mutational vectors
PCT/US2000/023457 WO2001015740A1 (en)	1999-08-27	2000-08-25	Single-stranded oligodeoxynucleotide mutational vectors

Publications (1)

Publication Number	Publication Date
ATE478687T1 true ATE478687T1 (de)	2010-09-15

Family

ID=23519459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00959442T ATE478687T1 (de)	1999-08-27	2000-08-25	Zur mutation geeignete einzelsträngige oligonukleotid vektoren

Country Status (15)

Country	Link
US (3)	US6271360B1 (de)
EP (3)	EP2266627B1 (de)
JP (2)	JP5697187B2 (de)
CN (1)	CN1384759B (de)
AT (1)	ATE478687T1 (de)
AU (2)	AU773242C (de)
BR (1)	BR0013590A (de)
CA (1)	CA2382120C (de)
DE (1)	DE60044876D1 (de)
DK (3)	DK1210123T3 (de)
ES (3)	ES2358292T3 (de)
NZ (1)	NZ517942A (de)
PT (3)	PT2266627E (de)
WO (1)	WO2001015740A1 (de)
ZA (1)	ZA200201228B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6652607B2 (en)	1999-07-07	2003-11-25	The Lubrizol Corporation	Concentrated emulsion for making an aqueous hydrocarbon fuel
EP1212406A1 (de) *	1999-08-20	2002-06-12	University Of Delaware	Zellfreies testverfahren für zielgerichtete genveränderungen und konversionen von pflanzengenen
US6271360B1 (en) *	1999-08-27	2001-08-07	Valigen (Us), Inc.	Single-stranded oligodeoxynucleotide mutational vectors
AR025996A1 (es)	1999-10-07	2002-12-26	Valigen Us Inc	Plantas no transgenicas resistentes a los herbicidas.
US6936467B2 (en) *	2000-03-27	2005-08-30	University Of Delaware	Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
EP1268768A2 (de) *	2000-03-27	2003-01-02	University Of Delaware	Gezielte chromosomale genom-änderungen mit modifizierten einzelsträngigen oligonukleotiden
AU2001263271A1 (en) *	2000-05-17	2001-11-26	University Of Delaware	Plant gene targeting using oligonucleotides
NZ524366A (en) *	2000-07-27	2005-12-23	Univ Delaware	Methods for enhancing targeted gene alteration using oligonucleotides
US7053195B1 (en) *	2001-06-12	2006-05-30	Syngenta Participatious Ag	Locked nucleic acid containing heteropolymers and related methods
WO2003013437A2 (en) *	2001-08-07	2003-02-20	University Of Delaware	Compositions and methods for the prevention and treatment of huntington's disease
US20040096880A1 (en) *	2001-08-07	2004-05-20	Kmiec Eric B.	Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
EP1448766A2 (de) *	2001-09-27	2004-08-25	University Of Delaware	Coisogene eukaryontische zellansammlungen
EP1446503A2 (de) *	2001-09-27	2004-08-18	University Of Delaware	Zusammensetzung und verfahren zur verbesserung der oligonukleotidgesteuerten veränderung von nukleinsäuresequenzen
WO2003075856A2 (en) *	2002-03-07	2003-09-18	University Of Delaware	Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
GB0218803D0 (en) *	2002-08-13	2002-09-18	Nl Kanker I	Targeted gene modification by single-standed DNA oligonucleotides
AU2003282477A1 (en) *	2002-10-07	2004-05-04	Napro Bio Therapeutics, Inc.	Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration
US6929917B2 (en) *	2002-11-18	2005-08-16	Pregentis	Method for cloning of a rare, specifically mutated cell
US20070072815A1 (en) *	2004-05-04	2007-03-29	Kmiec Eric B	Methods and kits to increase the efficiency of oligonucleotide-directed nucleic acid sequence alteration
CA2636771C (en)	2006-01-12	2016-05-24	Greg F.W. Gocal	Epsps mutants
CA2893168C (en)	2006-06-28	2017-11-07	Nucelis Inc.	Fatty acid blends and uses therefor
EP2182056B1 (de)	2006-10-06	2015-12-23	BASF Plant Science GmbH	Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenen nicht-humanen Organismen
US9102948B2 (en)	2006-11-17	2015-08-11	22Nd Century Limited, Llc	Regulating alkaloids
CN108130336A (zh) *	2007-10-05	2018-06-08	赛布斯欧洲公司	芸苔属中突变的乙酰羟酸合酶基因
US20110023352A1 (en) *	2007-12-27	2011-02-03	Knuth Mark E	Alkylester fatty acid blends and uses therefor
JP2011520471A (ja) *	2008-05-23	2011-07-21	サイバスオイルズ，エルエルシー	酵母を使用したスクアレンの生成
CN102216453B (zh)	2008-09-26	2014-02-05	巴斯夫农化产品有限公司	除草剂-抗性的ahas-突变体及使用方法
DE112009003708T5 (de)	2008-12-12	2012-09-13	Basf Plant Science Gmbh	Desaturasen und Verfahren zur Herstellung mehrfach ungesättigter Fettsäuren in transgenenOrganismen
CN102666837A (zh)	2009-11-23	2012-09-12	纽塞利斯公司	使用酵母产生角鲨烯的方法和组合物
US20120122223A1 (en)	2010-08-03	2012-05-17	Cibus Us Llc	Mutated protoporphyrinogen ix oxidase (ppx) genes
UA112969C2 (uk)	2010-08-03	2016-11-25	Сібас Юс Ллс	Рослина, стійка до одного або більше ррх-інгібуючих гербіцидів, яка містить мутантний ген протопорфіриноген ix оксидази (ррх)
WO2012028673A1 (en)	2010-09-02	2012-03-08	Ludwig-Maximilians-Universitaet Muenchen	Spontaneous organogenesis in plants
EP2426204A1 (de)	2010-09-02	2012-03-07	Ludwig-Maximilians-Universität München	Spontane Knöllchenorganogenese in Pflanzen
KR101137285B1 (ko)	2010-10-28	2012-04-20	위월드 주식회사	초소형 광대역 송수신 안테나 피더
KR20150041788A (ko)	2012-08-17	2015-04-17	다우 아그로사이언시즈 엘엘씨	식물에서의 트랜스진 발현을 위한 옥수수 비번역 영역의 용도
EA037142B1 (ru)	2013-03-14	2021-02-10	Сибас Юс Ллс	Мутированные гены алленоксидсинтазы 2 (aos2)
CA2905135C (en)	2013-03-15	2022-10-25	Cibus Us Llc	Targeted gene modification using oligonucleotide-mediated gene repair
US12331303B2 (en)	2013-03-15	2025-06-17	Cibus Us Llc	Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
EP4136963B1 (de)	2013-03-15	2026-01-21	Cibus US LLC	Verfahren und zusammensetzungen zur erhöhung der effizienz von gezielter genmodifizierung mit oligonukleotidvermittelter genreparatur
US9957515B2 (en)	2013-03-15	2018-05-01	Cibus Us Llc	Methods and compositions for targeted gene modification
KR102450868B1 (ko)	2014-03-14	2022-10-06	시버스 유에스 엘엘씨	올리고뉴클레오타이드 매개 유전자 보수를 사용한 표적화된 유전자 변형의 효율을 증가시키기 위한 방법 및 조성물
CN109072248A (zh)	2016-02-09	2018-12-21	希博斯美国有限公司	采用寡核苷酸介导的基因修复提高靶向基因修饰的效率的方法和组合物
US10584363B2 (en)	2016-06-03	2020-03-10	Takara Bio Usa, Inc.	Methods of producing and using single-stranded deoxyribonucleic acids and compositions for use in practicing the same
CN118830491A (zh)	2018-01-09	2024-10-25	希博斯美国有限公司	防碎基因和突变
UA129286C2 (uk)	2018-04-04	2025-03-12	Сайбас Юес Ллс	Гени fad2 і мутації

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2731844B2 (ja) *	1987-04-22	1998-03-25	ザ・ユニヴァーシティー・オブ・コネチカット	哺乳動物の細胞にポリヌクレオチドを導入するキャリア及び水溶性高分子複合体並びにその導入方法
DE59108644D1 (de) *	1990-07-02	1997-05-07	Hoechst Ag	Oligonucleotid-analoge mit terminalen 3'-3'-bzw. 5'-5'-Internucleotidverknüpfungen
EP0666923A1 (de)	1991-09-05	1995-08-16	The University Of Connecticut	Gezielte bereitstellung von poly- oder oligonukleotiden in zellen
US5556959A (en)	1993-01-22	1996-09-17	Pharmacia P-L Biochemicals Inc.	Indocarbocyanine-linked phosphoramidites
US5808044A (en) *	1993-01-22	1998-09-15	Pharmacia Biotech Inc.	Indocarbocyanine and benzindocarbocyanine phosphoramidites
DE733059T1 (de)	1993-12-09	1997-08-28	Univ Jefferson	Verbindungen und verfahren zur ortsspezifischen mutation in eukaryotischen zellen
US5780296A (en)	1995-01-17	1998-07-14	Thomas Jefferson University	Compositions and methods to promote homologous recombination in eukaryotic cells and organisms
WO1996040271A1 (en) *	1995-06-07	1996-12-19	Yale University	Treatment of hemoglobinopathies
US5908777A (en) *	1995-06-23	1999-06-01	University Of Pittsburgh	Lipidic vector for nucleic acid delivery
FR2736926B1 (fr)	1995-07-19	1997-08-22	Rhone Poulenc Agrochimie	5-enol pyruvylshikimate-3-phosphate synthase mutee, gene codant pour cette proteine et plantes transformees contenant ce gene
US5760012A (en)	1996-05-01	1998-06-02	Thomas Jefferson University	Methods and compounds for curing diseases caused by mutations
US5888983A (en)	1996-05-01	1999-03-30	Thomas Jefferson University	Method and oligonucleobase compounds for curing diseases caused by mutations
US5731181A (en)	1996-06-17	1998-03-24	Thomas Jefferson University	Chimeric mutational vectors having non-natural nucleotides
CA2282729A1 (en) *	1997-02-26	1998-09-03	The General Hospital Corporation	Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of alzheimer's disease
EP0979311A1 (de)	1997-04-30	2000-02-16	Of The University Of Minnesota Regents	$i(IN VIVO)VERWENDUNG REKOMBINAGENISCHER OLIGONUKLEOBASEN ZUR KORREKTUR GENETISCHER DEFEKTE IN HEPATOZYTEN
US6524613B1 (en)	1997-04-30	2003-02-25	Regents Of The University Of Minnesota	Hepatocellular chimeraplasty
GB9711015D0 (en)	1997-05-28	1997-07-23	Zeneca Ltd	Improvements in or relating to organic compounds
US5986086A (en) *	1997-06-20	1999-11-16	Amersham Pharmacia Biotech Inc.	Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides
US7094606B2 (en) *	1997-08-05	2006-08-22	Arntzen Charles J	Use of mixed duplex oligonucleotides to effect localized genetic changes in plants
CA2309719A1 (en)	1997-11-18	1999-05-27	Pioneer Hi-Bred International, Inc.	Targeted manipulation of genes in plants
US6004804A (en)	1998-05-12	1999-12-21	Kimeragen, Inc.	Non-chimeric mutational vectors
US6271360B1 (en) *	1999-08-27	2001-08-07	Valigen (Us), Inc.	Single-stranded oligodeoxynucleotide mutational vectors
EP3183223A1 (de)	2014-08-21	2017-06-28	Corning Incorporated	Verfahren zur verhinderung von blasen in schichtglasartikeln und daraus geformte verbundglasartikel

1999
- 1999-08-27 US US09/384,960 patent/US6271360B1/en not_active Expired - Lifetime
2000
- 2000-08-25 AU AU70767/00A patent/AU773242C/en not_active Expired
- 2000-08-25 DK DK00959442.5T patent/DK1210123T3/da active
- 2000-08-25 PT PT100086024T patent/PT2266627E/pt unknown
- 2000-08-25 CA CA2382120A patent/CA2382120C/en not_active Expired - Lifetime
- 2000-08-25 PT PT00959442T patent/PT1210123E/pt unknown
- 2000-08-25 BR BR0013590-9A patent/BR0013590A/pt not_active Application Discontinuation
- 2000-08-25 WO PCT/US2000/023457 patent/WO2001015740A1/en not_active Ceased
- 2000-08-25 US US09/645,889 patent/US6479292B1/en not_active Expired - Lifetime
- 2000-08-25 ES ES00959442T patent/ES2358292T3/es not_active Expired - Lifetime
- 2000-08-25 AT AT00959442T patent/ATE478687T1/de active
- 2000-08-25 DK DK10008602.4T patent/DK2266627T3/da active
- 2000-08-25 EP EP20100008602 patent/EP2266627B1/de not_active Expired - Lifetime
- 2000-08-25 EP EP20100183960 patent/EP2324856B1/de not_active Expired - Lifetime
- 2000-08-25 DE DE60044876T patent/DE60044876D1/de not_active Expired - Lifetime
- 2000-08-25 NZ NZ517942A patent/NZ517942A/en not_active IP Right Cessation
- 2000-08-25 ES ES10008602.4T patent/ES2542530T3/es not_active Expired - Lifetime
- 2000-08-25 EP EP00959442A patent/EP1210123B1/de not_active Expired - Lifetime
- 2000-08-25 CN CN008149968A patent/CN1384759B/zh not_active Expired - Lifetime
- 2000-08-25 ES ES10183960.3T patent/ES2544727T3/es not_active Expired - Lifetime
- 2000-08-25 PT PT101839603T patent/PT2324856E/pt unknown
- 2000-08-25 DK DK10183960.3T patent/DK2324856T3/en active
- 2000-08-25 JP JP2001520151A patent/JP5697187B2/ja not_active Expired - Lifetime
2002
- 2002-02-13 ZA ZA200201228A patent/ZA200201228B/en unknown
- 2002-11-12 US US10/292,856 patent/US7060500B2/en not_active Expired - Lifetime
2004
- 2004-08-19 AU AU2004205139A patent/AU2004205139B2/en not_active Expired
2012
- 2012-05-10 JP JP2012108528A patent/JP5813571B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP2266627A1 (de)	2010-12-29
JP2003508451A (ja)	2003-03-04
US6271360B1 (en)	2001-08-07
DK2266627T3 (da)	2015-06-15
JP2012184246A (ja)	2012-09-27
ES2544727T3 (es)	2015-09-03
JP5813571B2 (ja)	2015-11-17
DE60044876D1 (de)	2010-10-07
AU2004205139A1 (en)	2004-09-16
CA2382120A1 (en)	2001-03-08
BR0013590A (pt)	2002-05-07
EP2266627B1 (de)	2015-04-22
PT2266627E (pt)	2015-08-25
AU2004205139B2 (en)	2008-01-10
ES2542530T3 (es)	2015-08-06
AU773242C (en)	2005-04-07
JP5697187B2 (ja)	2015-04-08
ZA200201228B (en)	2003-05-28
US7060500B2 (en)	2006-06-13
US6479292B1 (en)	2002-11-12
EP1210123A1 (de)	2002-06-05
CA2382120C (en)	2013-10-29
AU7076700A (en)	2001-03-26
PT1210123E (pt)	2010-11-30
EP2324856A1 (de)	2011-05-25
US20040023392A1 (en)	2004-02-05
CN1384759B (zh)	2013-05-22
DK2324856T3 (en)	2015-08-03
EP2324856B1 (de)	2015-05-06
WO2001015740A1 (en)	2001-03-08
EP1210123A4 (de)	2004-08-18
NZ517942A (en)	2004-07-30
AU773242B2 (en)	2004-05-20
DK1210123T3 (da)	2010-12-20
CN1384759A (zh)	2002-12-11
PT2324856E (pt)	2015-09-03
ES2358292T3 (es)	2011-05-09
EP1210123B1 (de)	2010-08-25

Legal Events

Date

Code

Title

Description

2011-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1210123

Country of ref document: EP

Publication	Publication Date	Title
ATE478687T1 (de)	2010-09-15	Zur mutation geeignete einzelsträngige oligonukleotid vektoren
KR100386337B1 (ko)	2004-03-24	진핵세포에서부위-특이적돌연변이를위한화합물과그방법
ATE412054T1 (de)	2008-11-15	Delta-endotoxin gene und verfahren zu ihrer verwendung
WO2019103442A3 (ko)	2019-07-18	CRISPR/Cpf1 시스템을 이용한 유전체 편집용 조성물 및 이의 용도
PT1068311E (pt)	2011-07-20	Processos e meios de obter fenótipos modificados
EP0827410A4 (de)	1999-05-12	Verfahren zür einführung und expression von genen in tierischen zellen
CN106795521A (zh)	2017-05-31	用于修饰所靶向基因座的方法和组合物
CY1109161T1 (el)	2014-07-02	Dna που κωδικοποιει συνθαση δεοξυ-υπουσινης φυτου, διαγονιδιακα φυτα και μεθοδος ελεγχου γηρασμου και προγραμματισμενου θανατου κυτταρουσε φυτα
BR0209745A (pt)	2004-08-10	Cromossomas artificiais de plantas, usos e dos mesmos e método para preparação de cromossomas artificiais de plantas
CN107922949A (zh)	2018-04-17	用于通过同源重组的基于crispr/cas的基因组编辑的化合物和方法
CA2191795A1 (en)	1995-12-07	Antisense oligonucleotide modulation of raf gene expression
KR20100051795A (ko)	2010-05-18	향상된 변형 올리고뉴클레오티드를 이용한 표적화 뉴클레오티드 교환
JP6958917B2 (ja)	2021-11-02	遺伝子ノックイン細胞の作製方法
MX2010003891A (es)	2010-09-07	Genes sinteticos que codifican cry1ac.
CA2263958A1 (en)	1997-02-13	Homologous recombination in mismatch repair inactivated eukaryotic cells
JP7700222B2 (ja)	2025-06-30	編集効率が向上したプライム編集ベースの遺伝子編集用組成物およびその用途
KR102679001B1 (ko)	2024-06-28	신규의 개량된 염기 편집 또는 교정용 융합단백질 및 이의 용도
KR102699756B1 (ko)	2024-08-29	편집 효율이 향상된 프라임 편집 기반 유전자 교정용 조성물 및 이의 용도
WO2001061030A3 (en)	2002-08-29	LIBRARIES OF OPTIMUM SUBSEQUENCE REGIONS OF mRNA AND GENOMIC DNA FOR CONTROL OF GENE EXPRESSION
Bhattarai	2021	Epigenetic modifications and its basic mechanism
MXPA02012557A (es)	2004-07-30	Composiciones y metodos para la modificacion de la expresion del gen.
MXPA02004782A (es)	2004-09-10	Genes del empequenecimiento del sorgo y metodos de uso.
EP4549565A1 (de)	2025-05-07	Tracrrna-einheit und genomeditierverfahren
WO1988001645A1 (en)	1988-03-10	Transformation of an organism using antisense rna or promoter occlusion technique
KR20190023602A (ko)	2019-03-08	생식조절인자의 유전적 조작 및 이의 용도